On December 28, 2023, the 13th CCTV Financial Forum in Hong Kong, with the theme of ‘Technology Innovation: Activating New Drivers for Economic Development’, was held in Hong Kong. The forum aimed to facilitate discussions and exchanges on how technology innovation can empower high-quality economic development.

Hong Kong Special Administrative Region Chief Executive John Lee, National Committee Member of the Chinese People’s Political Consultative Conference (CPPCC) and Chairman and Chief Editor of Hong Kong Ta Kung Wen Wei Media Group, Lee Tai-hung, and Peng Jianming, Member of the Editorial Board Meeting and General Manager of the Central Radio and Television Station, were among the participants in the forum and delivered speeches.

Dr. Ke Xu, Co-founder and CEO of META Pharmaceuticals, was also invited to participate in the forum. During the dialogue session, Dr. Xu shared META’s achievements in utilizing artificial intelligence for biomedical research and development. He explained that META is a company focused on developing original drugs for autoimmune diseases, metabolic disorders, and rare diseases. Dr. Xu highlighted that the company has made breakthroughs in chronic disease treatment by regulating the metabolic vitality of immune cells to achieve immune system function modulation.

Dr. Ke Xu, in an interview after the forum, emphasized that the company’s use of AI and machine learning technologies can significantly enhance the efficiency of drug discovery and accelerate the progression of drugs into clinical trials. He also expressed the hope for better integration of innovative AI applications, enabling META to contribute to First-in-class original drugs and continue exploring and benefiting patients in the field of biomedicine.